20 November 2017 – SoftBank Uber Investment Finally Happening

Deals

People have been waiting for SoftBank’s proposed investment in Uber to be confirmed, and it now appears as though it’s happening, after Uber revealed it has come to an agreement with a consortium featuring SoftBank and Dragoneer over a deal.

Consumer and information robotics developer UBTech is in the process of raising $400m in a Tencent-led round set to value it at about $4bn, according to the South China Morning Post.

There are several prominent online car marketplaces in China and one of them, Huashenghaoche, has become the latest to close a nine-figure round. Minsheng Financial Leasing, the vehicle leasing branch of China Minsheng Bank, has invested $150m in the company, which also offers car leasing options, and whose existing investors reportedly include JD.com and Dongfeng Motor Group.

Maoyan, which agreed in September to merge with certain assets of another China-based online ticketing platform, Weiying, has received $150m in funding from Tencent, the internet group that is also one of Weiying’s key investors.

Elsewhere in China, Particle, the owner of personalised news aggregation app Yidian Zixun, has raised $112m in funding in a round that included government guidance fund Long De Cheng Zhang Culture Communication.

GV has led a $107m series D round for immuno-oncology drug developer Arcus Biosciences that included existing backers Taiho Ventures and Celgene, taking its total funding to $227m.

SIG-backed peer-to-peer lending platform 9f has raised an undisclosed amount in a series C round it claimed was sized in the nine-figure range.

Temasek, the Singapore state-owned investment firm, has led an $87.5m series D round for Poshmark, a social fashion marketplace backed by Shea Ventures, the corporate venturing arm of JF Shea.

Graphcore, the creator of a machine intelligence processing unit, has raised $50m in a series C round that included Robert Bosch Venture Capital, Samsung Catalyst Fund and Dell Technologies Capital, all of which also backed its $30m series B just five months ago.

Funds

Aster Capital, the French VC firm sponsored by corporates Solvay, Alstom and Schneider Electric, has closed just over $280m in financing from undisclosed backers, bringing the overall capital it has under management to almost $590m.

On GUV, Johns Hopkins University joined forces with US-based healthcare investment firm Deerfield Management to launch a $65m commercialisation fund called Bluefield Innovations aimed at the university’s therapeutic research.

On GGV, Ireland Strategic Investment Fund (ISIF), the country’s sovereign wealth vehicle, provided a cornerstone investment to a €250m ($294m) patient capital fund for Ireland-based small and medium-sized enterprises (SMEs).

Exits

China-based online consumer lending platform Qudian had some notable success in its US IPO last month, raising $900m after it floated well above its range.

Yixin Group, the automotive e-commerce and finance platform spun out of BitAuto in 2014, has generated $867m in a Hong Kong IPO that also represented an exit for investors Tencent, JD.com and Baidu.

LexinFintech, the Chinese operator of consumer lending and instalment buying platform Fenqile, has filed for a $500 initial public offering.

Mashable was valued at $250m as of its last funding round, but with no additional funding forthcoming, it has been forced into a sale to Ziff Davis for only $50m.

Corporates emerged practically unscathed from the Theranos disaster, but CapitalG, the growth equity unit formerly known as Google Capital, has found itself in a sticky situation with healthcare clinic advertiser Outcome Health.

On GUV, we had two news about IPOs. First, US-based immunotherapy developer Arsanis, backed by research institute European Molecular Biology Laboratory’s investment arm EMBL Ventures, set its pricing range at $15 to $17 – meaning it could raise $61m if it floats at the top of the range.

Apellis Pharmaceuticals, a US-based biopharmaceutical spinout from University of Pennsylvania, meanwhile raised $150m in its IPO, floating on the Nasdaq Global Select Market.

On GGV, OnPoint Technologies, the strategic investment vehicle for the US Army, has exited US-based fabless semiconductor producer InVisage Technologies following its acquisition by electronics producer Apple.


“Funky Chunk” Kevin MacLeod (incompetech.com)
Licensed under Creative Commons: By Attribution 3.0

15 May 2017 – SoftBank Leads Improbable $502m Investment and Much More

Deals

The $5.5bn round on-demand ride provider Didi Chuxing just confirmed was closed at a $50bn valuation that means it is closing ground with rival Uber in terms of size, and the company has indicated it will use the cash to finally expand globally.

Yixin Group, the online automotive marketplace spinout of motoring e-commerce firm Bitauto, has secured $580m in funding commitments in a round that includes both its parent company and internet group Tencent.

Indonesia-based online media, e-commerce and financial services platform Garena has rebranded itself as Sea and revealed $550m in funding from conglomerates JG Summit Holdings and Uni-President Enterprises.

SoftBank is continuing its investment spree, leading a $502m series B round for Improbable, a UK company developing software that will make the creation of large-scale virtual worlds possible.

SoftBank has also led a $360m round for Guardant Health, the developer of a liquid biopsy test for cancer diagnosis, and will help commercialise Guardant’s technology in Asia, Africa and the Middle East.

Modernizing Medicine had raised a total of $87m in funding as of the $38m series E round it closed in 2015, but the electronic health record system developer has taken a big jump with a $231m investment by private equity firm Warburg Pincus.

Online payment services provider PayU has invested $120m in digital lending platform lending platform Kreditech as part of a strategic partnership agreement.

There’s been more action in the on-demand transport sector, with Spain-based Cabify having raised $100m from an undisclosed single investor as part of a series D round it aims to close at $500m.

India-based mobile wallet operator MobiKwik is working on its own nine-figure round and is reportedly in talks with BlackRock, Bank of Baroda and Canara Bank over a round that will value it at about $1bn.

Music royalties platform Kobalt has raised $75m in a Hearst Entertainment-led series D round that valued the company at $775m post-money.

Signifyd has secured $56m in an American Express Ventures-backed series C round that increased its overall funding to almost $100m.

Social music app developer Smule has raised $54m in a round led by Tencent that reportedly values it at just over $600m.

Customer data software provider Gainsight has closed a $52m series E round featuring Salesforce Ventures and Cisco Investments that took its overall funding to more than $150m.

We’ve already talked about the biggest government venturing deal with Guardant Health just now, but what about the university venturing world? We haven’t had any mind-blowingly large rounds there this week, but still a few interesting ones – among these is SiFive, a US-based fabless provider of customised semiconductors based on UC Berkeley research, which raised $8.5m in a series B round that included spinout-focused investment firm Osage University Partners.

Funds

Dell has brought its corporate venturing unit, Dell Technologies Capital, out of stealth, revealing a 50-strong portfolio and 27 exits in the past five years.

China has launched a RMB17.8bn ($2.6bn) venture capital fund aimed at startups in industries of strategic importance, such as IT, energy conservation and environmental protection, advanced materials and equipment manufacturing.

International Finance Corporation (IFC), the private sector-focused investment arm of multilateral financial institution World Bank, has agreed to put $10m into the Stellaris Venture Partners India I fund.

BDC Capital, the investment arm of the government-owned Business Development Bank of Canada, injected C$5m ($3.6m) into the StandUp Ventures Fund I.

Exits

Ovid Therapeutics has gone public in a $75m IPO that provided exits for Sanofi-Genzyme BioVentures and Takeda, the latter its largest external investor.


“Funky Chunk” Kevin MacLeod (incompetech.com)
Licensed under Creative Commons: By Attribution 3.0